- Home
- Publications
- Publication Search
- Publication Details
Title
Insulin-Like Growth Factor Pathway and the Thyroid
Authors
Keywords
-
Journal
Frontiers in Endocrinology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-06-04
DOI
10.3389/fendo.2021.653627
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Teprotumumab for the Treatment of Active Thyroid Eye Disease
- (2020) Raymond S. Douglas et al. NEW ENGLAND JOURNAL OF MEDICINE
- Teprotumumab: First Approval
- (2020) Anthony Markham DRUGS
- Nuclear localization and actions of the insulin-like growth factor 1 (IGF-1) system components: Transcriptional regulation and DNA damage response
- (2020) Elzbieta Poreba et al. MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH
- New Insights from IGF-IR Stimulating Activity Analyses: Pathological Considerations
- (2020) Joseph A.M.J.L. Janssen Cells
- Teprotumumab for Dysthyroid Optic Neuropathy
- (2020) Connie M. Sears et al. OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY
- Teprotumumab for Optic Neuropathy in Thyroid Eye Disease
- (2020) Dane H. Slentz et al. JAMA Ophthalmology
- Thyroid abnormalities in patients with extreme insulin resistance syndromes
- (2019) Yevgeniya Kushchayeva et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- IGF-IEc Expression Is Associated With Advanced Differentiated Thyroid Cancer
- (2019) APOSTOLOS K. KARAGIANNIS et al. ANTICANCER RESEARCH
- Activation of the IGF Axis in Thyroid Cancer: Implications for Tumorigenesis and Treatment
- (2019) Livia Manzella et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The influence of the lack of insulin receptor substrate 2 (IRS2) on the thyroid gland
- (2019) Maria Carmen Iglesias-Osma et al. Scientific Reports
- DECREASE IN ACROMEGALY-ASSOCIATED THYROID ENLARGEMENT AFTER NORMALIZATION OF IGF-1 LEVELS: A PROSPECTIVE OBSERVATION AND IN VITRO STUDY
- (2019) Zhiyong Chen et al. Endocrine Practice
- Insulin-like growth factor-1 enhances the expression of functional TSH receptor in orbital fibroblasts from thyroid-associated ophthalmopathy
- (2019) Ji Sun Paik et al. IMMUNOBIOLOGY
- Modulation of hyaluronan polymer size regulates proliferation of perimysial fibroblasts in thyroid eye disease
- (2018) Ruiqi Ma et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Insulin-like growth factor-I receptor and thyroid-associated ophthalmopathy
- (2018) Terry J Smith et al. ENDOCRINE REVIEWS
- Thyrocyte-specific deletion of insulin and IGF-1 receptors induces papillary thyroid carcinoma-like lesions through EGFR pathway activation
- (2018) Sangmi Ock et al. INTERNATIONAL JOURNAL OF CANCER
- Challenges in Orphan Drug Development: Identification of Effective Therapy for Thyroid-Associated Ophthalmopathy
- (2018) Terry J. Smith Annual Review of Pharmacology and Toxicology
- Teprotumumab for Thyroid-Associated Ophthalmopathy
- (2017) Terry J. Smith et al. NEW ENGLAND JOURNAL OF MEDICINE
- Update of IGF-1 receptor inhibitor (ganitumab, dalotuzumab, cixutumumab, teprotumumab and figitumumab) effects on cancer therapy
- (2017) Xiao Qu et al. Oncotarget
- Activity of R1507, a monoclonal antibody to the insulin-like growth factor-1 receptor (IGF1R), in patients (pts) with recurrent or refractory Ewing's sarcoma family of tumors (ESFT): Results of a phase II SARC study.
- (2017) A. S. Pappo et al. JOURNAL OF CLINICAL ONCOLOGY
- Graves’ Disease
- (2016) Terry J. Smith et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phase 1b study of safety, tolerability and efficacy of R1507, a monoclonal antibody to IGF-1R in combination with multiple standard oncology regimens in patients with advanced solid malignancies
- (2014) Daruka Mahadevan et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Teprotumumab, an IGF-1R Blocking Monoclonal Antibody Inhibits TSH and IGF-1 Action in Fibrocytes
- (2014) Hong Chen et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Pathogenesis of Graves’ orbitopathy: A 2010 update
- (2014) T. J. Smith JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- B Cells from Patients with Graves' Disease Aberrantly Express the IGF-1 Receptor: Implications for Disease Pathogenesis
- (2014) R. S. Douglas et al. JOURNAL OF IMMUNOLOGY
- Evidence for an Association between Thyroid-Stimulating Hormone and Insulin-Like Growth Factor 1 Receptors: A Tale of Two Antigens Implicated in Graves' Disease
- (2014) S. Tsui et al. JOURNAL OF IMMUNOLOGY
- Insulin and insulin-like growth factor 1 receptors are required for normal expression of imprinted genes
- (2014) Jeremie Boucher et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The adverse events profile of anti-IGF-1R monoclonal antibodies in cancer therapy
- (2013) Honghai Ma et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- IGF-1 receptor deficiency in thyrocytes impairs thyroid hormone secretion and completely inhibits TSH-stimulated goiter
- (2013) Sangmi Ock et al. FASEB JOURNAL
- Thyroid nodules in acromegaly
- (2012) Amelia Rogozinski et al. Arquivos Brasileiros de Endocrinologia e Metabologia
- Duodenal adenocarcinoma with neuroendocrine features in a patient with acromegaly and thyroid papillary adenocarcinoma: a unique combination of endocrine neoplasia
- (2012) Ken-ichiro Kato et al. ENDOCRINE JOURNAL
- Thyroid cancer in patients with acromegaly: a case–control study
- (2012) Maíra Cristina Carvalho dos Santos et al. Pituitary
- -Arrestin-biased agonism as the central mechanism of action for insulin-like growth factor 1 receptor-targeting antibodies in Ewing's sarcoma
- (2012) H. Zheng et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Three Endocrine Neoplasms: An Unusual Combination of Pheochromocytoma, Pituitary Adenoma, and Papillary Thyroid Carcinoma
- (2012) James C. Sisson et al. THYROID
- Randomized Phase II Study of Erlotinib in Combination With Placebo or R1507, a Monoclonal Antibody to Insulin-Like Growth Factor-1 Receptor, for Advanced-Stage Non–Small-Cell Lung Cancer
- (2011) Suresh S. Ramalingam et al. JOURNAL OF CLINICAL ONCOLOGY
- A humanized anti-IGF-1R monoclonal antibody (R1507) and/or metformin enhance gemcitabine-induced apoptosis in pancreatic cancer cells
- (2011) Soichi Takiguchi ONCOLOGY REPORTS
- Molecular regulation of thyroid gland function
- (2011) Margaret C Eggo Current Opinion in Endocrinology Diabetes and Obesity
- A Phase I Study of Weekly R1507, A Human Monoclonal Antibody Insulin-like Growth Factor-I Receptor Antagonist, in Patients with Advanced Solid Tumors
- (2010) R. Kurzrock et al. CLINICAL CANCER RESEARCH
- Neutral Antibodies to the TSH Receptor Are Present in Graves’ Disease and Regulate Selective Signaling Cascades
- (2010) Syed A. Morshed et al. ENDOCRINOLOGY
- Thyroid hormone-mediated growth and differentiation of growth plate chondrocytes involves IGF-1 modulation of β-catenin signaling
- (2010) Lai Wang et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Insulin Receptor Isoforms and Insulin-Like Growth Factor Receptor in Human Follicular Cell Precursors from Papillary Thyroid Cancer and Normal Thyroid
- (2010) Roberta Malaguarnera et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Insulin-Like Growth Factor-I Regulation of Immune Function: A Potential Therapeutic Target in Autoimmune Diseases?
- (2010) T. J. Smith PHARMACOLOGICAL REVIEWS
- Thyroid cancer is the most common cancer associated with acromegaly
- (2010) Bennur Esen Gullu et al. Pituitary
- Differentiation of murine embryonic stem cells to thyrocytes requires insulin and insulin-like growth factor-1
- (2009) Maria C. Arufe et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Crosstalk Between Epidermal Growth Factor Receptor- and Insulin-Like Growth Factor-1 Receptor Signaling: Implications for Cancer Therapy
- (2009) J. Veeken et al. CURRENT CANCER DRUG TARGETS
- The Thyroid-Stimulating Hormone Receptor: Impact of Thyroid-Stimulating Hormone and Thyroid-Stimulating Hormone Receptor Antibodies on Multimerization, Cleavage, and Signaling
- (2009) Rauf Latif et al. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
- Divergent Frequencies of IGF-I Receptor-Expressing Blood Lymphocytes in Monozygotic Twin Pairs Discordant for Graves’ Disease: Evidence for a Phenotypic Signature Ascribable to Nongenetic Factors
- (2009) Raymond S. Douglas et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Diminished and Irregular Thyrotropin Secretion with Preserved Diurnal Rhythm in Patients with Active Acromegaly
- (2009) Ferdinand Roelfsema et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Distinct Modes of Activation of Phosphatidylinositol 3-Kinase in Response to Cyclic Adenosine 3′, 5′-Monophosphate or Insulin-Like Growth Factor I Play Different Roles in Regulation of Cyclin D1 and p27Kip1in FRTL-5 Cells
- (2008) Toshiaki Fukushima et al. ENDOCRINOLOGY
- Characterization of Thyrotropin Receptor Antibody-Induced Signaling Cascades
- (2008) Syed A. Morshed et al. ENDOCRINOLOGY
- G13-dependent Activation of MAPK by Thyrotropin
- (2008) Thomas R. H. Büch et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started